Literature DB >> 19786606

Susceptibilities of 23 Desulfovibrio isolates from humans.

Ken-ichi Nakao1, Kaori Tanaka, Suguru Ichiishi, Hiroshige Mikamo, Toshiyuki Shibata, Kunitomo Watanabe.   

Abstract

Antimicrobial susceptibilities of 23 strains of Desulfovibrio spp. were tested by Etest. Generally, Desulfovibrio spp. were highly susceptible to sulbactam-ampicillin, meropenem, clindamycin, metronidazole, and chloramphenicol: MIC(90)s of 6, 4, 0.19, 0.25, and 8 microg/ml, respectively. In addition, these strains generally showed high MICs to piperacillin and piperacillin-tazobactam. Desulfovibrio fairfieldensis (eight strains) was the species least susceptible to most agents, especially beta-lactams, and was the only species resistant to fluoroquinolones. Desulfovibrio desulfuricans strain Essex 6 isolates were less susceptible to beta-lactams than D. desulfuricans strain MB isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786606      PMCID: PMC2786338          DOI: 10.1128/AAC.00630-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  First isolation of Desulfovibrio species as part of a polymicrobial infection from a brain abscess.

Authors:  A Lozniewski; P Maurer; H Schuhmacher; J P Carlier; F Mory
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-08       Impact factor: 3.267

2.  Antimicrobial susceptibilities of clinical Desulfovibrio isolates.

Authors:  A Lozniewski; R Labia; X Haristoy; F Mory
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis.

Authors:  J Loubinoux; F Mory; I A Pereira; A E Le Faou
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.

Authors:  Yumi A Warren; Diane M Citron; C Vreni Merriam; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria.

Authors:  T D Wikins; L V Holdeman; I J Abramson; W E Moore
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

6.  Sulfate-reducing anaerobic bacteria in human feces.

Authors:  H Beerens; C Romond
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

7.  Sulfate-reducing bacteria in association with human periodontitis.

Authors:  P S Langendijk; J T Hanssen; J S Van der Hoeven
Journal:  J Clin Periodontol       Date:  2000-12       Impact factor: 8.728

8.  Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans.

Authors:  Anne-Sophie Morin; Laurent Poirel; Francine Mory; Roger Labia; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 9.  Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections.

Authors:  Ellie J C Goldstein; Diane M Citron; Victoria A Peraino; Sally A Cross
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Anaerobic vibrio-like organisms cultured from blood: Desulfovibrio desulfuricans and Succinivibrio species.

Authors:  R K Porschen; P Chan
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

View more
  6 in total

1.  Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis.

Authors:  Isabel Verstreken; Wim Laleman; Georges Wauters; Jan Verhaegen
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Desulfovibrio legallii prosthetic shoulder joint infection and review of antimicrobial susceptibility and clinical characteristics of Desulfovibrio infections.

Authors:  Shawn Vasoo; Erin L Mason; Daniel R Gustafson; Scott A Cunningham; Nicolynn C Cole; Emily A Vetter; Scott P Steinmann; Walter R Wilson; Robin Patel; Elie F Berbari; Nancy K Henry
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

3.  Hybrid cluster proteins and flavodiiron proteins afford protection to Desulfovibrio vulgaris upon macrophage infection.

Authors:  Mafalda C O Figueiredo; Susana A L Lobo; Sara H Sousa; Fábio P Pereira; Judy D Wall; Lígia S Nobre; Lígia M Saraiva
Journal:  J Bacteriol       Date:  2013-04-05       Impact factor: 3.490

4.  A Case of Liver Abscess with Desulfovibrio desulfuricans Bacteremia.

Authors:  Saho Koyano; Keita Tatsuno; Mitsuhiro Okazaki; Kiyofumi Ohkusu; Takashi Sasaki; Ryoichi Saito; Shu Okugawa; Kyoji Moriya
Journal:  Case Rep Infect Dis       Date:  2015-01-08

5.  First case of Desulfovibrio desulfuricans bacteraemia successfully identified using MALDI-TOF MS.

Authors:  R Nasreddine; M A Argudin; M Herpol; V Y Miendje Deyi; N Dauby
Journal:  New Microbes New Infect       Date:  2019-10-23

6.  Effects of treatment with enrofloxacin or tulathromycin on fecal microbiota composition and genetic function of dairy calves.

Authors:  Carla Foditsch; Richard V V Pereira; Julie D Siler; Craig Altier; Lorin D Warnick
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.